Figure 2

(A) Determination of (a) particle size distribution, (b) stability (after 3 months), and (c) stability (after 6 months) of Nano-EE by dynamic light scattering (DLS), (B) Drug releasing profiles of EE from Nano-EE in simulated gastric fluid (SGF) (red line) (pH = 1.2) and simulated intestinal fluid (SIF) (blue line) (pH = 7.5) by HPLC analysis, and (C) Scanning electron microscopic (SEM) images of Nano-EE at (a) 1000 times (b) 30,000 times.